Header Logo

Connection

ADAM S GARDEN to Radiation Injuries

Back to Details
This is a "connection" page, showing publications ADAM S GARDEN has written about Radiation Injuries.
ADAM S GARDEN
Connection Strength
2.283
Radiation Injuries
  1. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1110-20.
    View in: PubMed
    Score: 0.165
  2. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):438-44.
    View in: PubMed
    Score: 0.161
  3. How to reduce radiation-related toxicity in patients with cancer of the head and neck. Curr Oncol Rep. 2006 Mar; 8(2):140-5.
    View in: PubMed
    Score: 0.153
  4. Mucositis: current management and investigations. Semin Radiat Oncol. 2003 Jul; 13(3):267-73.
    View in: PubMed
    Score: 0.127
  5. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol. 2020 01; 142:133-139.
    View in: PubMed
    Score: 0.097
  6. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.
    View in: PubMed
    Score: 0.086
  7. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck. 2017 08; 39(8):1516-1523.
    View in: PubMed
    Score: 0.083
  8. Long-Term, Prospective Performance of the MD?Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):700-708.
    View in: PubMed
    Score: 0.078
  9. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):30-41.
    View in: PubMed
    Score: 0.077
  10. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol. 2016 Feb; 118(2):315-22.
    View in: PubMed
    Score: 0.076
  11. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Radiat Oncol. 2014 Nov 26; 9:255.
    View in: PubMed
    Score: 0.070
  12. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26.
    View in: PubMed
    Score: 0.069
  13. Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):983-9.
    View in: PubMed
    Score: 0.061
  14. Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma. Ophthalmic Plast Reconstr Surg. 2012 May-Jun; 28(3):208-12.
    View in: PubMed
    Score: 0.059
  15. Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer. Radiat Oncol. 2012 Feb 08; 7:19.
    View in: PubMed
    Score: 0.058
  16. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer. Int J Radiat Oncol Biol Phys. 2010 Jun 01; 77(2):455-61.
    View in: PubMed
    Score: 0.049
  17. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study. Head Neck. 2009 Aug; 31(8):1031-8.
    View in: PubMed
    Score: 0.048
  18. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage. 2009 Oct; 38(4):522-32.
    View in: PubMed
    Score: 0.048
  19. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009 Aug 01; 27(22):3684-90.
    View in: PubMed
    Score: 0.048
  20. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008 Nov 01; 26(31):5119-25.
    View in: PubMed
    Score: 0.045
  21. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
    View in: PubMed
    Score: 0.045
  22. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):747-55.
    View in: PubMed
    Score: 0.044
  23. Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. AJNR Am J Neuroradiol. 2008 Mar; 29(3):558-62.
    View in: PubMed
    Score: 0.044
  24. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):719-30.
    View in: PubMed
    Score: 0.042
  25. Head and neck radiation and mucositis. Curr Opin Support Palliat Care. 2007 Apr; 1(1):30-4.
    View in: PubMed
    Score: 0.041
  26. Self-management intervention improves patient adherence to swallowing exercises during radiation for head and neck cancer. Head Neck. 2024 Nov; 46(11):2878-2889.
    View in: PubMed
    Score: 0.034
  27. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Semin Radiat Oncol. 2004 Apr; 14(2):103-9.
    View in: PubMed
    Score: 0.033
  28. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):674-81.
    View in: PubMed
    Score: 0.033
  29. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003 Feb 01; 55(2):322-8.
    View in: PubMed
    Score: 0.031
  30. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol. 1999 Aug; 17(8):2390-5.
    View in: PubMed
    Score: 0.024
  31. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113.
    View in: PubMed
    Score: 0.022
  32. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck. 2017 10; 39(10):2048-2056.
    View in: PubMed
    Score: 0.021
  33. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. Radiother Oncol. 2016 12; 121(3):381-386.
    View in: PubMed
    Score: 0.020
  34. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Jun 01; 35(3):455-62.
    View in: PubMed
    Score: 0.019
  35. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367.
    View in: PubMed
    Score: 0.019
  36. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):344-352.
    View in: PubMed
    Score: 0.018
  37. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):13-20.
    View in: PubMed
    Score: 0.017
  38. Radiation-induced injury to the visual pathway. Radiother Oncol. 1994 Jan; 30(1):17-25.
    View in: PubMed
    Score: 0.016
  39. Anisotropic margin expansions in 6 anatomic directions for oropharyngeal image guided radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):596-601.
    View in: PubMed
    Score: 0.016
  40. Results of a changing treatment philosophy for children with stage I Hodgkin's disease: a 35-year experience. Med Pediatr Oncol. 1991; 19(4):214-20.
    View in: PubMed
    Score: 0.013
  41. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1356-65.
    View in: PubMed
    Score: 0.013
  42. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009 Oct 01; 115(19):4636-44.
    View in: PubMed
    Score: 0.012
  43. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1333-8.
    View in: PubMed
    Score: 0.012
  44. A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. Radiother Oncol. 2002 May; 63(2):187-93.
    View in: PubMed
    Score: 0.007
  45. Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys. 2001 Nov 15; 51(4):952-8.
    View in: PubMed
    Score: 0.007
  46. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):571-8.
    View in: PubMed
    Score: 0.007
  47. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000 Aug 01; 48(1):7-16.
    View in: PubMed
    Score: 0.006
  48. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1997 Aug 01; 39(1):127-35.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.